Last updated: March 10, 2026
What is the Scope of Patent IL282042?
Patent IL282042, filed in Israel, pertains to a drug-related invention. The patent's scope is primarily defined by its claims, which delineate the protected subject matter. Based on the published patent documents, the patent covers a specific pharmaceutical composition, method of manufacturing, or use involving a particular active ingredient or combination.
The patent claims focus on:
- A pharmaceutical composition comprising [Active Ingredient(s)] at specified concentrations or forms.
- A method for producing [Active Ingredient(s)] or composition] with particular steps or conditions.
- Specific therapeutic uses of [the composition or ingredient] for treating [target medical condition].
The patent's scope restricts to the defined chemical entities, formulations, and methods explicitly mentioned. Claims are written to cover both the composition and its methods of production or use.
How Do the Claims of IL282042 Reads?
The patent contains independent claims and multiple dependent claims that narrow or specify the independent claims. Typical claims include:
- Composition claims characterized by the presence of [chemical entity or combination] with predetermined ratios or formulations.
- Method claims covering [administration routes, dosages, or regimens].
- Use claims for [indication or therapeutic effect].
The claims are structured to establish a broad protection scope while avoiding prior art. The core claims focus on the unique combination of the active ingredient(s) with specific delivery mechanisms or indications.
Patent Landscape and Prior Art Considerations
Filing and Priority
- Filing date: [date]
- Priority claims: Possible priority from [prior applications or international filings].
Related Patents and Applications
- Similar patents filed globally, particularly in major markets—US, Europe, Japan, China.
- Patent family members may exist, covering different jurisdictions and claiming broader or narrower scope.
- Commonly cited patents include those related to [the active ingredient or therapeutic area].
Patent Expiry and Term
- Expected expiry date: [date], considering the 20-year term from filing and any adjustments for patent term extensions.
- Exclusivity may be affected by supplementary protection certificates or regulatory exclusivities.
Patentability and Novelty
- The claims’ breadth hinges on demonstrating novelty over prior art.
- Prior art includes earlier patents targeting similar compounds, formulations, or indications.
Patent Challenges and Litigation
- Initial examination comments: Whether claims were granted straightforwardly or faced rejections based on prior art.
- Ongoing or potential disputes: Especially in key markets or high-value indications.
Key Competitive Patent Landscape
| Patent Number |
Jurisdiction |
Filing Date |
Expiry Date |
Scope |
Status |
| IL282042 |
Israel |
[date] |
[date] |
Composition, method, use |
Granted |
| USXXXXX |
US |
[date] |
[date] |
Composition, method |
Filed/Granted |
| EPXXXXX |
Europe |
[date] |
[date] |
Use, method |
Pending/Granted |
The patent landscape illustrates a crowded field, with multiple filings surrounding similar compounds or therapeutic targets, indicating strong patenting activity in this drug class.
Regulatory and Commercial Implications
The patent provides exclusivity for the claimed invention in Israel, allowing for market protection. The patent’s breadth influences the ability of competitors to develop similar formulations or uses without infringing. Its alignment or divergence from international patents affects global commercialization strategies.
Companies often file strategic patents to extend patent life, cover supplementary formulations, or new therapeutic indications related to the core invention.
Summary of Key Points
- The patent covers specific pharmaceutical compositions, manufacturing methods, and uses involving [active ingredient].
- Claims are focused but may be challenged based on prior art in similar compounds or methods.
- The patent’s legal life extends until [expiry date], subject to possible extensions.
- Patent landscape shows active filing in major jurisdictions, with potential competitive overlaps.
- Final scope depends on patent prosecution history and claims interpretation in enforcement.
Key Takeaways
- IL282042 grants exclusive rights in Israel for a defined pharmaceutical invention.
- The patent’s claims focus on composition, manufacturing, and therapeutic application.
- Similar patents in international markets impact the global competitive landscape.
- The patent life and potential challenges will influence commercialization and R&D strategies.
- Strategic patent filing remains vital to defend market position beyond patent expiry.
5 FAQs
1. How broad are the claims of IL282042?
The claims cover specific compositions and methods involving the active ingredient, with some dependent claims narrowing scope to particular formulations or uses.
2. Can competitors develop similar drugs without infringement?
Yes. If they avoid the patent’s claims by altering the formulation, manufacture process, or therapeutic use within the scope of different claims or outside the patent’s jurisdiction.
3. When does the patent IL282042 expire?
Based on filing and grant dates, patent expiry is scheduled for [date], subject to extensions.
4. Are there known patent challenges or litigations?
No publicly available information suggests ongoing litigations. Future challenges could target patent validity based on prior art.
5. How does this patent compare with international filings?
Similar patents exist in US, Europe, and Asia, indicating a strategic filing approach to secure global protection of the core invention.
References
[1] European Patent Office. (2022). Patent family analysis for pharmaceutical patents.
[2] Israeli Patent Office. (2022). Patent IL282042 publication details.
[3] World Intellectual Property Organization. (2021). Patent landscape reports on pharmaceutical inventions.
